Written by Mark Meyers. Men can be a different sort. We can think differently, share differently and act a different way. We can also deal with stress and grief differently. As fathers of children with cancer or other life-threatening illness, we must lead through a...read more
Novartis’ groundbreaking CAR-T cancer therapy is one big step closer to reaching patients. A panel of outside experts convened by the FDA voted 10-0 Wednesday to recommend the approval of Novartis’ CAR-T therapy, called CTL019, for the treatment of children and young adults with advanced leukemia.read more
CureSearch for Children’s Cancer announced today the opening of the application window for funding up to $75,000 direct costs per year for up to three years (and a 10% indirect cost allowance) for the 2017 Young Investigator Award in Pediatric Oncology Drug Development.read more
Did You Know?
What We Fund
Among adults, less than 5% of those with cancer are enrolled in clinical trials. Yet for children, more than 60% of those with cancer participate in some form of clinical trial. CureSearch supports clinical trials that show promise in making a difference for children with cancer, today.